Naturalnano Inc. (OTC: NNAN) gained 11.11% to $0.0010, with strong volume of 38.63 million shares traded. Shares of the material science company were boosted after the announcement of an exclusive joint development and supply deal with Sparta Armor for improved vehicle and body armor products. Based in Pittsford, N.Y., NaturalNano focuses on the development and commercialization of advanced nanocomposites.

Clean Coal Technologies Inc. (PINK: CCTC) jumped 22.81% to $0.0350, above-average volume of 9.23 million shares. Headquartered in New York City, NY, Clean Coal Technologies owns a patented process technology to convert coal into a cleaner burning fuel source.

Mammoth Energy Group Inc. (PINK: MMTE) gained 25.00% to $0.0005, on high volume of 53.47 million shares. Mammoth Energy Group is focused on acquiring, developing and operating strategic mining energy reserves in locations throughout the world.

Fox Petroleum Inc. (PINK: FXPT) advanced 20.00% to $0.0120, with volume of 5.36 million shares traded. Fox Petroleum, a development stage company, engages in the identification, exploration, acquisition, and development of prospective oil and gas properties. The company on Tuesday filed its latest quarterly report with the SEC.

AMR Corp. (PINK: AAMRQ) rose 3.23% to $0.415, on volume of 6.90 million shares. AMR, through its principal subsidiary, American Airlines Inc., provides scheduled jet service to approximately 160 destinations throughout North America, the Caribbean, Latin America, Europe, and Asia.

Generex Biotechnology Corp. (OTC: GNBT) dropped 29.50% to $0.184, on above-average volume of 11.85 million shares. It has a 52-week range of $0.08 – $0.32. Generex subsidiary Antigen Express has recently outlined advantages of the Ii-Key immunotherapeutic vaccine, following positive interim data from its Phase 2b breast cancer trial announced last month at the San Antonio Breast Cancer Symposium.

MultiCell Technologies Inc. (OTC: MCET) slipped 9.09% to $0.0050, with volume of 7.86 million shares traded. MultiCell Technologies, together with its majority owned subsidiary Xenogenics, engages in the development of novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, cancer, cardiac and hepatic disease and some types of autoimmune diseases. 

• Need fast service and cheap rates from a broker? Buy stock online at my favorite brokerage
• See today’s top stock picks and market analysis
• Want more? Check out the message board buzz for these stocks
• See what newsletters are recommending these stock picks
• Get breaking news alerts on these stocks: http://thestockmarketwatch.com/
• This newsletter has been helping traders make a killing on these stocks. Click here for a 25% discount offer.

About BeaconEquity.com

BeaconEquity.com is committed to producing the highest-quality insight and analysis of small-cap stocks, emerging technology stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily OTC stocks in the stock market today, which have traditionally been shunned by Wall Street. We have particular expertise with renewable energy stocks, biotech stocks, oil stocks, green energy stocks and internet stocks. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.

Beacon Equity Group Disclaimer

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Beaconequity.com is a wholly-owned subsidiary of BlueWave Advisors.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.